Therapeutic Uses
Immunosuppressants
API Family
Mycophenolic acid
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
Mycophenolic Acid-d3, 1185242-90-3
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
No -Refer MSDS for accurate information
Mycophenolic Acid-d3 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Mycophenolic Acid-d3 usage and description
Mycophenolic acid D3 is a deuterated version of the immunosuppressive drug mycophenolic acid. Mycophenolic acid is widely used as an immunosuppressant in organ transplantation and autoimmune diseases. Its mechanism of action involves inhibiting the enzyme inosine monophosphate dehydrogenase, which is essential for the de novo synthesis of guanine nucleotides. This leads to a reduction in the production of T and B lymphocytes, which are responsible for the immune response.
Mycophenolic acid D3 has the same mechanism of action as mycophenolic acid, but with the added benefit of being labeled with deuterium. This labeling is useful in pharmacokinetic studies as it allows for the measurement of drug metabolism and distribution in the body. Deuterium labeling also increases drug stability and reduces the risk of drug-drug interactions.
Mycophenolic acid D3 is available as a powder for oral administration and is typically used in clinical research studies. It is important to note that mycophenolic acid D3 is not currently approved for clinical use and should only be used in research settings.
In summary, mycophenolic acid D3 is a deuterated version of the immunosuppressive drug mycophenolic acid that is used for pharmacokinetic studies. Its mechanism of action involves inhibiting the enzyme inosine monophosphate dehydrogenase, leading to a reduction in T and B lymphocyte production. Mycophenolic acid D3 has the added benefit of increased drug stability and reduced risk of drug-drug interactions.
